KPV 10mg

Description

KPV is a melanocortin-derived tripeptide investigated in intestinal and epithelial inflammation models, with research centered on barrier biology and cytokine modulation.

What it is

KPV (Lys-Pro-Val) is a melanocortin-derived tripeptide profile explored for anti-inflammatory effects in gut and epithelial model systems.

Mechanism snapshot

• Investigated for cytokine-modulatory and inflammation-resolution signaling.
• Studied for intestinal transport and uptake dynamics, including PepT1-related pathways.
• Evaluated in mucosal-barrier and epithelial-injury model frameworks.

Research programs

• Murine inflammatory bowel disease model studies.
• Peptide transport and local-delivery pathway analyses.
• Melanocortin-system anti-inflammatory mechanism exploration.

Limitations

• Most efficacy signals are model-based rather than clinical outcomes.
• Dose/formulation comparability across studies is limited.
• Translation to broad therapeutic claims is not established.

Selected references

• Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease - PubMed 2008
• PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation - PubMed 2008
• The Melanocortin System in Inflammatory Bowel Diseases: Insights into Its Mechanisms and Therapeutic Potentials - PubMed 2023

Ordering

Add this item to your cart, submit your shipping details at checkout, and wait for your order confirmation. Interac e-Transfer instructions are sent after the order request is received.